Literature DB >> 24396961

Combined application of 5% natamycin and 0.2% fluconazole for the treatment of fungal keratitis.

Hua Gong1, Xiangming Gong2.   

Abstract

PURPOSE: To observe the clinical efficacy of combined use of 5% natamycin and 0.2% fluconazole for the treatment of fungal keratitis.
METHODS: A total of 65 cases diagnosed with fungal keratitis by direct smear and/or fungus culture from January 2010 to January 2013 were enrolled in this study. The duration from the onset of symptoms to admission to our ophthalmic center ranged from 9 to 90 d (mean 29.5+/-19.1 d) in the severe group, which significantly differed from the 7 to 36 d (mean 16.6+/-7.1 d) in the non-severe group (P<0.01). All cases were divided into non-severe and severe groups based on the degree of corneal inflammation. All cases were treated with topical use of 5% natamycin and 0.2% fluconazole once per hour. The same clinical and examination protocols were adopted for both groups.
RESULTS: In the non-severe group, 23 of the 24 patients (95.8%) were healed, and 1 (4.2%) showed treatment effica cy. In the severe group, 12 of 41 patients (29.3%) were healed, 11(26.8%) showed clinical efficacy, and 18(43.9%) showed no efficacy. The patients between two groups significantly differed in terms of efficacy (P<0.01).
CONCLUSION: Combined use of 5% natamycin and 0.2% fluconazole is efficacious in treating fungal keratitis, especially mild or moderate infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24396961

Source DB:  PubMed          Journal:  Eye Sci


  2 in total

Review 1.  Review of clinical and basic approaches of fungal keratitis.

Authors:  Jie Wu; Wen-Song Zhang; Jing Zhao; Hong-Yan Zhou
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

2.  Combined intrastromal injection of amphotericin B and topical fluconazole in the treatment of resistant cases of keratomycosis: a retrospective study.

Authors:  Waled Mahdy Nada; Mahmoud A Al Aswad; Wael M El-Haig
Journal:  Clin Ophthalmol       Date:  2017-05-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.